On Tuesday, state Department of Health officials said 425 people in New York of 13,000 nationwide received steroid shots suspected in the outbreak, the Associated Press reported.
Bassett doesn’t stock the steroid product linked to the outbreak, said the statement, which applies to all hospitals in the network — Bassett Medical Center in Cooperstown, A.O. Fox Memorial Hospital in Oneonta, Cobleskill Regional Hospital, Little Falls Hospital, O’Connor Hospital in Delhi and Tri-Town Regional Hospital in Sidney.
However, Bassett hospitals have purchased other medical products from the company, the statement said. As a precaution, all products connected to the company have been removed from pharmacy shelves at Bassett and no others from the firm are being purchased.
Bassett officials also said the steroid injections being discussed in this outbreak aren’t the same as the epidurals given to women for childbirth or C-sections.
The Federal Drug Administration is working with the CDC and state authorities to investigate the outbreak.
The outbreak been associated with preservative-free methylprednisolone acetate (80mg/ml), an injectable steroid produced and distributed by NECC, an FDA statement said.
CDC’s interim data show that all infected patients received an injection with this product.
NECC, following an FDA recommendation, announced a voluntary recall Saturday of all its products from its facility in Framingham.
As of Oct. 3, NECC had voluntarily shut down.
The potentially contaminated medication was from three lots from NECC and was given starting May 21, the CDC said.